Nam Q Bui (Nam Bui)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Topics

Circulating Tumor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Clinical sarcoma research

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Minggui Pan, Maggie Yuxi Zhou, Chen Jiang, Zheyang Zhang, Nam Q Bui, Jeffrey Y Bien, Amanda Siy, Ninah S Achacoso, Aleyda V Solorzano-Pinto, Pamela Tse, Elaine Chung, Sachdev Thomas, Laurel A Habel, Kristen N Ganjoo
Sex-Dependent Prognosis of Patients with Advanced Soft Tissue Sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Nam Q Bui, Neda Nemat-Gorgani, Ajay Subramanian, Ileana A Torres, Marta Lohman, Timothy J Sears, Matt van de Rijn, Gregory W Charville, Hans-Christoph Becker, David S Wang, Gloria L Hwang, Kristen N Ganjoo, Everett J Moding
Monitoring sarcoma response to immune checkpoint inhibition and local cryotherapy with circulating tumor DNA analysis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Matthew A Ingham, Jacob B Allred, Li Chen, Biswasjit Das, Bose S Kochupurakkal, Katherine Gano, Suzanne George, Steven Attia, Melissa A Burgess, Mahesh Seetharam, Sosipatros A Boikos, Nam Q Bui, James L Chen, Julia L Close, Gregory M Cote, Premal H Thaker, Susan Percy Ivy, Sminu Bose, Alan D' Andrea, Adrian Mariño-Enriquez, Geoffrey I Shapiro, Gary K Schwartz
Phase II Study of Olaparib and Temozolomide for Advanced Uterine Leiomyosarcoma (NCI Protocol 10250). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Stefano Testa, Nam Q Bui, Kristen N Ganjoo
Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis. Cancer research communications 3 (7) (2023)
David G P van IJzendoorn, Magdalena Matusiak, Gregory W Charville, Geert Spierenburg, Sushama Varma, Deana R C Colburg, Michiel Adreanus van de Sande, Kirsten van Langevelde, David G Mohler, Kristen N Ganjoo, Nam Q Bui, Raffi S Avedian, Judith V M G Bovée, Robert Steffner, Robert B West, Matt van de Rijn
Interactions in CSF1-Driven Tenosynovial Giant Cell Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (22) (2022)
Livia Ulicna, Samuel C Kimmey, Christopher M Weber, Grace M Allard, Aihui Wang, Nam Q Bui, Sean C Bendall, Gerald R Crabtree, Gregory R Bean, Capucine Van Rechem
The Interaction of SWI/SNF with the Ribosome Regulates Translation and Confers Sensitivity to Translation Pathway Inhibitors in Cancers with Complex Perturbations. Cancer research 82 (16) (2022)
Mizuo Ando, Yuki Saito, Guorong Xu, Nam Q Bui, Kate Medetgul-Ernar, Minya Pu, Kathleen M Fisch, Shuling Ren, Akihiro Sakai, Takahito Fukusumi, Chao Liu, Sunny Haft, John Pang, Adam Mark, Daria A Gaykalova, Theresa Guo, Alexander V Favorov, Srinivasan Yegnasubramanian, Elana J Fertig, Patrick K Ha, Pablo Tamayo, Tatsuya Yamasoba, Trey Ideker, Karen Messer, Joseph A Califano
Publisher Correction: Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers. Nature communications 10 (1) (2019)
Nam Q Bui, Joanna Przybyl, Sally E Trabucco, Garrett Frampton, Trevor Hastie, Matt van de Rijn, Kristen N Ganjoo
A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis. Clinical sarcoma research 9 (2019)
Mizuo Ando, Yuki Saito, Guorong Xu, Nam Q Bui, Kate Medetgul-Ernar, Minya Pu, Kathleen M Fisch, Shuling Ren, Akihiro Sakai, Takahito Fukusumi, Chao Liu, Sunny Haft, John Pang, Adam Mark, Daria A Gaykalova, Theresa Guo, Alexander V Favorov, Srinivasan Yegnasubramanian, Elana J Fertig, Patrick K Ha, Pablo Tamayo, Tatsuya Yamasoba, Trey Ideker, Karen Messer, Joseph A Califano
Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers. Nature communications 10 (1) (2019)
Rebecca Shatsky, Barbara A Parker, Nam Q Bui, Teresa Helsten, Richard B Schwab, Sarah G Boles, Razelle Kurzrock
Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies. Molecular cancer therapeutics 18 (5) (2019)
Nam Q Bui, Nikhil Kamat, Vinod Ravi, Sant Chawla, Marti Lohman, Kristen N Ganjoo
A multicenter phase II study of Q3 week or weekly paclitaxel in combination with bevacizumab for the treatment of metastatic or unresectable angiosarcoma. Rare tumors 10 (2018)